Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRent ExpenseRestructuring CostsRevenueShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Ratios

Acadia Healthcare Company (ACHC) Income from Non-Controlling Interests (2016 - 2026)

Acadia Healthcare Company (ACHC) has disclosed Income from Non-Controlling Interests for 12 consecutive years, with $359000.0 as the latest value for Q1 2026.

  • For Q1 2026, Income from Non-Controlling Interests fell 47.97% year-over-year to $359000.0; the TTM value through Mar 2026 reached $10.5 million, up 46.59%, while the annual FY2025 figure was $10.8 million, 22.28% up from the prior year.
  • Income from Non-Controlling Interests hit $359000.0 in Q1 2026 for Acadia Healthcare Company, up from $279000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $7.8 million in Q2 2025 and bottomed at $279000.0 in Q4 2025.
  • Average Income from Non-Controlling Interests over 5 years is $1.9 million, with a median of $1.9 million recorded in 2022.
  • Year-over-year, Income from Non-Controlling Interests surged 339.59% in 2024 and then plummeted 71.09% in 2025.
  • Acadia Healthcare Company's Income from Non-Controlling Interests stood at $2.0 million in 2022, then grew by 0.35% to $2.0 million in 2023, then crashed by 54.93% to $914000.0 in 2024, then plummeted by 69.47% to $279000.0 in 2025, then increased by 28.67% to $359000.0 in 2026.
  • According to Business Quant data, Income from Non-Controlling Interests over the past three periods came in at $359000.0, $279000.0, and $2.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.